Finance

Lists
RUBICON:NSE
Rubicon Research Ltd
1 520,00 INR
-1,31%
(-20,20) 1D
13 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RUBICON...
Open
1 540,20 INR
High
1 549,80 INR
Low
1 500,00 INR
Mkt. cap
251,61 მლრ.
Avg. vol.
239,19 ათ.
Volume
198,62 ათ.
Dividend
0,10%
Quarterly dividend
0,38 INR
Ex-dividend date
7 აგვ. 2026
P/E ratio
87,09
52-wk high
1 899,00 INR
52-wk low
570,75 INR
EPS
17,45 INR
No. of employees
1 ათ.
Open
1 540,20 INR
High
1 549,80 INR
Low
1 500,00 INR
Mkt. cap
251,61 მლრ.
Avg. vol.
239,19 ათ.
Volume
198,62 ათ.
Dividend
0,10%
Quarterly dividend
0,38 INR
Ex-dividend date
7 აგვ. 2026
P/E ratio
87,09
52-wk high
1 899,00 INR
52-wk low
570,75 INR
EPS
17,45 INR
No. of employees
1 ათ.
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
6 საათის წინ
3 Indian Growth Stocks With ROE Above 22%
Profile
Rubicon Research is an Indian pharmaceutical company located in Mumbai. The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
About Rubicon Research Ltd
CEO-
Employees1,29 ათ.
Founded1999
Headquarters-
SectorPharmaceutical industry
Last report
14 აგვ. 2026
Fiscal period
Q1 2027
5,08 INR / 4,40 INR
+15,45%beat
Revenue / Est. (INR)
5,34 მლრდ. / 5,13 მლრდ.
+4,20%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
4,12 მლრდ.
4,76 მლრდ.
5,14 მლრდ.
5,34 მლრდ.
Cost of goods sold
1,27 მლრდ.
1,57 მლრდ.
1,86 მლრდ.
1,69 მლრდ.
Cost of revenue
1,27 მლრდ.
1,57 მლრდ.
1,86 მლრდ.
1,69 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
633,59 მლნ.
663,73 მლნ.
699,04 მლნ.
856,66 მლნ.
Operating expense
2,03 მლრდ.
2,22 მლრდ.
2,21 მლრდ.
2,51 მლრდ.
Total operating expenses
3,30 მლრდ.
3,79 მლრდ.
4,07 მლრდ.
4,20 მლრდ.
Operating income
824,26 მლნ.
965,73 მლნ.
1,06 მლრდ.
1,14 მლრდ.
Other non operating income
6,97 მლნ.
37,87 მლნ.
-157,07 მლნ.
56,83 მლნ.
EBT including unusual items
717,05 მლნ.
905,86 მლნ.
986,87 მლნ.
1,10 მლრდ.
EBT excluding unusual items
717,05 მლნ.
905,86 მლნ.
996,82 მლნ.
1,10 მლრდ.
Income tax expense
178,53 მლნ.
177,89 მლნ.
219,02 მლნ.
255,91 მლნ.
Effective tax rate
24,90%
19,64%
22,19%
23,19%
Other operating expenses
1,28 მლრდ.
1,44 მლრდ.
1,39 მლრდ.
1,51 მლრდ.
Net income
538,52 მლნ.
727,97 მლნ.
767,85 მლნ.
847,81 მლნ.
Net profit margin
13,07%
15,31%
14,94%
15,87%
Earnings per share
3,47
4,41
4,60
5,08
Interest and investment income
-
-
79,68 მლნ.
-
Interest expense
-114,18 მლნ.
-97,74 მლნ.
-
-92,88 მლნ.
Net interest expenses
-114,18 მლნ.
-97,74 მლნ.
79,68 მლნ.
-92,88 მლნ.
Depreciation and amortization charges
118,71 მლნ.
115,53 მლნ.
122,66 მლნ.
151,39 მლნ.
EBITDA
976,82 მლნ.
1,12 მლრდ.
1,14 მლრდ.
1,21 მლრდ.
Gain or loss from assets sale
7,63 მლნ.
-
-
-
AI content may include mistakes. Learn more
Google აპები